Abstract Details

Title Clinical Metabolomic Profiling for the Diagnosis of Neurometabolic Disorders for Global Developmental Delay, Seizures

Topic Child Neurology and Developmental Neurology

Presentation(s) (-)

Poster/Presentation
Number 002

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Meeta Wagle Cardon, MD PRESENTER	Dr. Wagle Cardon has nothing to disclose.
	No disclosure on file
	No disclosure on file
Sarah Elsea	The institution of Sarah Elsea has received research support from NIH. The institution of Sarah Elsea has received research support from Speragen, Inc. The institution of Sarah Elsea has received research support from PTC Therapeutics, Inc. The institution of Sarah Elsea has received research support from PRISMS, Inc. The institution of Sarah Elsea has received research support from Warren Alpert Foundation. Sarah Elsea has received personal compensation in the range of $0-$499 for serving as a Grant Reviewer with NIH. Sarah Elsea has received personal compensation in the range of $0-$499 for serving as a Reviewer with CDMRP-DOD.
Lisa T. Emrick, MD (Department of Neurology & Developmental Neuroscience)	Dr. Emrick has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Arkema. The institution of Dr. Emrick has received research support from Lysogene. The institution of Dr. Emrick has received research support from PTC. The institution of Dr. Emrick has received research support from Roche. The institution of Dr. Emrick has received research support from NIH.

��ɫ��